Recent advancements in genetic testing technology enable parents to select embryos based on predicted traits, raising significant ethical and social implications. While some parents use these tests to avoid hereditary diseases, others aim for more desirable traits, leading to fears of a return to eugenics. The medical community is wary, citing insufficient evidence backing the predictive capabilities of such tests and expressing concerns about their potential misuse.
The race to commercialize preimplantation genetic testing (PGT) is intensifying, with various startups emerging to offer comprehensive screening services. Critics argue that these can mislead parents about the nature of genetics and lead to societal inequalities based on perceived genetic hierarchies. The discussion of traits like intelligence stirs particularly controversial debates, as many fear it reinforces old prejudices and ignores the deeply intertwined roles of environment and privilege in human development.
Policy and ethical discussions surrounding this technology are crucial as it gains traction in society. Without proper regulation and a clear understanding of the implications of embryo selection technologies, the quest for a ‘perfect baby’ may yield unintended consequences, further complicating the nature versus nurture debate.
👉 Pročitaj original: MIT Technology Review – AI
